A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma. (Q45068216)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 May 2009

Language	Label	Description	Also known as
English	A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.	scientific article published on 27 May 2009

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

Stephen Duffull

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

D R Mould

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

K Sweeney

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

E Neylon

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

S Horwitz

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

F Sirotnak

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

M Fleisher

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

M E Saunders

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

O A O'Connor

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

0 references

publication date

27 May 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

86

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

190-196

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19474785%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Population pharmacokinetics of pemetrexed disodium (ALIMTA) in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Population pharmacokinetics of raltitrexed in patients with advanced solid tumours

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Effect of vitamin B12, folate, and dietary supplements on breast carcinoma chemotherapy--induced mucositis and neutropenia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Phase I trials of pemetrexed

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Understanding the cancer biology universe: enigmas, context and future prospects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

CLINICAL CALORIMETRY

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Forecasting individual pharmacokinetics

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

A size standard for pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Population pharmacodynamic model for ketorolac analgesia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

21 January 2018

Pralatrexate: an emerging new agent with activity in T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

7 January 2021

based on heuristic

inferred from DOI database lookup

Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorometric high-performance liquid chromatographic analysis of 10-deazaaminopterin, 10-ethyl-10-deazaaminopterin, and known metabolites

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

7 January 2021

based on heuristic

inferred from DOI database lookup

Human gene mapping 3. Baltimore Conference (1975). Third International Workshop on Human Gene Mapping. Report of the committee on the genetic constitution of autosomes other than chromosomes 1, 2, and 6

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

7 January 2021

based on heuristic

inferred from DOI database lookup

Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. I: A use of bootstrap standard error

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.80

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45068216&oldid=2143957008"